# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-015320
Filing Date
2026-04-06
Accepted
2026-04-06 16:37:38
Documents
16
Period of Report
2026-04-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 497017
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 633478
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 227405
| Complete submission text file | 0001493152-26-015320.txt |  | 2870391

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | immx-20251231.xsd | EX-101.SCH | 4006
5 | XBRL DEFINITION FILE | immx-20251231_def.xml | EX-101.DEF | 4220
6 | XBRL LABEL FILE | immx-20251231_lab.xml | EX-101.LAB | 54961
7 | XBRL PRESENTATION FILE | immx-20251231_pre.xml | EX-101.PRE | 43766
19 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 24671

Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41159 | Film No.: 26841753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)